Low-grade systemic inflammation is an independent risk factor for psoriasis, especially moderate to severe disease, results ...

and adherence among psoriasis patients treated with different biologics including tildrakizumab, risankizumab, guselkumab, and ustekinumab, with implications for clinical decision-making based on ...

Icotrokinra had more significant improvements than placebo for multiple skin clearance measures following 16 weeks of treatment for plaque psoriasis in adolescents and adults. Icotrokinra is ...

Many people who have psoriasis will experience the telltale sign of itchiness or burning. But for people with differing skin tones, that’s where the similarities may end. The symptoms of ...

EC president Ursula von der Leyen is scheduled to hold a call with the European pharmaceuticals industry. Credit: VYACHESLAV OSELEDKO via Getty Images. European Commission (EC) President Ursula von ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. The singer, one half of the folk-rock duo Simon & Garfunkel, has teamed with Sun Pharma to discuss how ...

Obesity was linked to reduced long-term effectiveness of biologic therapy in patients with severe plaque psoriasis in a study, with dysregulated innate immune responses contributing to treatment ...

In your practice, what are the rates of persistence and adherence to plaque psoriasis treatment, and what key factors influence these outcomes?

Scalp Psoriasis vs. Dandruff: What’s the Difference? This article was reviewed by Knox Beasley, MD. If you’re experiencing a flaking, itching scalp, you may do a quick self-diagnosis of dandruff.

Improved targeting of the molecular drivers of psoriasis has paved the way for new oral therapies that offer the potential for major responses in a majority of patients. Identification of better ...

Many people with psoriasis successfully undergo cosmetic procedures, but they should avoid treatments done directly on psoriasis lesions or during flare-ups, as this can worsen psoriasis. If a ...

BIOLOGIC therapies significantly reduce the risk of major adverse cardiovascular events (MACEs) in patients with psoriasis and psoriatic arthritis (PsA), offering potential heart health benefits ...